|4Apr 7, 4:52 PM ET

Omega Fund V GP Manager, Ltd. 4

4 · Nuvation Bio Inc. · Filed Apr 7, 2022

Insider Transaction Report

Form 4
Period: 2022-04-05
Transactions
  • Sale

    Common Stock

    2022-04-05$5.60/sh2,500,000$14,000,00020,457,340 total
Footnotes (1)
  • [F1]The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION